Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
MYGN Myriad Genetics, Inc. daily Stock Chart
MYGN [NASD]
Myriad Genetics, Inc.
Services | Research Services | USA
statements
Index- P/E- EPS (ttm)-0.21 Insider Own2.30% Shs Outstand74.56M Perf Week2.46%
Market Cap1.89B Forward P/E18.25 EPS next Y1.39 Insider Trans-11.68% Shs Float73.27M Perf Month7.40%
Income-15.30M PEG- EPS next Q0.31 Inst Own- Short Float15.11% Perf Quarter-5.96%
Sales835.10M P/S2.27 EPS this Y-95.70% Inst Trans- Short Ratio10.16 Perf Half Y3.89%
Book/sh14.58 P/B1.74 EPS next Y31.97% ROA-1.00% Target Price25.50 Perf Year-18.62%
Cash/sh1.91 P/C13.28 EPS next 5Y7.83% ROE-1.40% 52W Range20.10 - 48.40 Perf YTD-12.66%
Dividend- P/FCF22.81 EPS past 5Y-51.50% ROI0.90% 52W High-48.84% Beta0.92
Dividend %- Quick Ratio2.60 Sales past 5Y1.80% Gross Margin75.90% 52W Low23.18% ATR1.30
Employees2600 Current Ratio2.90 Sales Q/Q-7.90% Oper. Margin-1.70% RSI (14)42.86 Volatility3.60% 3.32%
OptionableYes Debt/Eq0.21 EPS Q/Q- Profit Margin-1.80% Rel Volume0.30 Prev Close25.39
ShortableYes LT Debt/Eq0.21 EarningsNov 04 AMC Payout- Avg Volume1.09M Price24.76
Recom3.10 SMA20-1.89% SMA50-11.05% SMA200-14.24% Volume271,246 Change-2.48%
Sep-26-19Downgrade BofA/Merrill Neutral → Underperform $30 → $28
Aug-14-19Downgrade Piper Jaffray Overweight → Neutral $45 → $40
Aug-02-19Upgrade BofA/Merrill Underperform → Neutral
Aug-01-19Upgrade Barclays Underweight → Equal Weight $18 → $40
Jul-29-19Downgrade Needham Strong Buy → Hold
Jul-09-19Downgrade Cowen Outperform → Market Perform
Mar-12-19Reiterated Needham Strong Buy $37 → $41
Jan-03-19Initiated Needham Strong Buy $36
Nov-30-18Upgrade Goldman Sell → Neutral
Oct-10-18Upgrade Piper Jaffray Neutral → Overweight
Jul-11-18Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-21-18Upgrade Morgan Stanley Underweight → Equal-Weight
Jan-29-18Initiated Goldman Sell $32
Jan-22-18Reiterated Barclays Equal Weight $30 → $35
Jan-05-18Initiated BTIG Research Buy $41
Oct-02-17Resumed Leerink Partners Mkt Perform $31
Aug-09-17Reiterated Barclays Equal Weight $28 → $26
Feb-08-17Upgrade Ladenburg Thalmann Sell → Neutral
Jan-18-17Initiated Deutsche Bank Sell $15
Oct-10-16Downgrade Ladenburg Thalmann Neutral → Sell
Dec-06-19 02:41PM  Hedge Funds Love Tri Pointe Group Inc (TPH) Way More Than These 3 Stocks Insider Monkey
Dec-05-19 09:24AM  Myriad Genetics Reports Favorable Study Result on Prequel Zacks
Dec-04-19 11:30AM  Myriad (MYGN) Up 18.4% Since Last Earnings Report: Can It Continue? Zacks
08:58AM  Myriad shares fall despite positive results on prenatal test MarketWatch
07:05AM  Myriads Prequel Prenatal Screen has Superior Sensitivity in Women with High BMI Undergoing Non-Invasive Prenatal Screening GlobeNewswire
Dec-03-19 07:05AM  Myriad Genetics to Present Multiple Studies on Breast Cancer at the 2019 San Antonio Breast Cancer Symposium GlobeNewswire
Nov-26-19 12:50PM  CLASS ACTION UPDATE for OSTK, MYGN and GRUB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:00AM  FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
10:21AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SEE, MYGN, ZEN and YJ GlobeNewswire
02:00AM  MYGN DEADLINE TODAY: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Myriad Genetics (MYGN) Investors of Todays Deadline to Move for Lead Plaintiff ACCESSWIRE
Nov-25-19 04:50PM  FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE +6.36%
03:15PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MYGN, CC and ET ACCESSWIRE
02:15PM  FINAL DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline Tomorrow ACCESSWIRE
12:30PM  SHAREHOLDER ALERT: MYGN TEUM ACB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
11:09AM  Myriad Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Myriad Genetics, Inc. To Contact The Firm Newsfile
09:51AM  DEADLINE ALERT - Myriad Genetics, Inc. (MYGN) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: November 26, 2019 ACCESSWIRE
09:28AM  MYGN FINAL DEADLINE: ROSEN LAW FIRM Reminds Myriad Genetics, Inc. Investors of Tuesday Deadline in Securities Class Action MYGN GlobeNewswire
09:23AM  CLASS ACTION UPDATE for CVET, MYGN, ZEN and PLT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:03AM  Myriad's BRACAnalysis Wins HBOC Risk Assessment Nod in Japan Zacks
Nov-24-19 11:10AM  FINAL DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
10:25AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MYGN, DOMO and PLT ACCESSWIRE
10:00AM  2-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching ACCESSWIRE
Nov-23-19 12:00PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. and Encourages Investors to Contact the Firm PR Newswire
10:00AM  3-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching ACCESSWIRE
Nov-22-19 06:01PM  4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching GlobeNewswire
04:15PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of UNIT, MYGN and ET ACCESSWIRE
03:00PM  DEADLINE ALERT - Myriad Genetics, Inc. (MYGN) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: November 26, 2019 GlobeNewswire
01:15PM  CLASS ACTION UPDATE for UNIT, MYGN and ET: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:49AM  INVESTOR ALERT - Myriad Genetics, Inc. (MYGN) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Deadline: November 26, 2019 ACCESSWIRE
10:37AM  Myriad Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Myriad Genetics, Inc. To Contact The Firm Newsfile
10:20AM  SHAREHOLDER ALERT: ADTN UNIT MYGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:01AM  Myriad Genetics' Test Added in Disease Activity Measure List Zacks
09:00AM  Myriad Genetics Shareholders: November 26, 2019 Filing Deadline in Class Action - Contact Lieff Cabraser ACCESSWIRE
07:39AM  CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Looming Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MYGN, OSTK, MTCH ACCESSWIRE
Nov-21-19 09:05PM  5-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching ACCESSWIRE
03:26PM  CLASS ACTION UPDATE for SNDL, MYGN, DOMO and ET: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
02:25PM  5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
02:17PM  SHAREHOLDER ALERT: MTCH MYGN TWTR CGC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:44AM  MYGN ALERT: Zhang Investor Law Reminds Investors of NOVEMBER 26 Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc. MYGN GlobeNewswire
09:32AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADTN, MTCH, MYGN and UA GlobeNewswire
07:05AM  Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients GlobeNewswire
Nov-20-19 09:20PM  6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
09:05PM  6-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching ACCESSWIRE
06:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MYGN, CC and RUHN ACCESSWIRE
06:15PM  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. and Encourages Investors to Contact the Firm Business Wire
03:30PM  CLASS ACTION UPDATE for OSTK, MYGN and DOMO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:52PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline MYGN GlobeNewswire
11:00AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MYGN, UBER and YJ ACCESSWIRE
10:48AM  INVESTOR ALERT - Myriad Genetics, Inc. (MYGN) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: November 26, 2019 ACCESSWIRE
07:05AM  The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis GlobeNewswire
06:50AM  CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Looming Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MYGN, OSTK, MTCH ACCESSWIRE
Nov-19-19 09:35PM  7-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
08:04PM  7-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching ACCESSWIRE
07:24PM  ROSEN, A GLOBALLY RANKED LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important Deadline in Securities Class Action MYGN GlobeNewswire
09:37AM  CLASS ACTION UPDATE for COF, WTRH, MYGN and SDC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:00AM  Myriad Genetics Investors: November 26, 2019 Filing Deadline in Class Action- Contact Lieff Cabraser ACCESSWIRE
Nov-18-19 08:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MO, MYGN and YJ ACCESSWIRE
08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - MYGN PR Newswire
10:50AM  SHAREHOLDER ALERT: SNDL WTRH MYGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:47AM  INVESTOR ALERT - Myriad Genetics, Inc. (MYGN) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 26, 2019 ACCESSWIRE
10:45AM  CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Looming Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MYGN, OSTK, MTCH ACCESSWIRE
07:18AM  8-DAY DEADLINE ALERT HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching ACCESSWIRE
Nov-17-19 10:50AM  CLASS ACTION UPDATE for SEE, COF and MYGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Nov-16-19 12:53PM  10-DAY DEADLINE ALERT HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching ACCESSWIRE
07:05AM  CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Approaching Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MYGN, OSTK, MTCH ACCESSWIRE
07:00AM  CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Approaching Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MYGN, COF, MTCH ACCESSWIRE
Nov-15-19 04:05PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PUMP, MYGN and UA ACCESSWIRE
03:00PM  Myriad Genetics, Inc. (MYGN), Overstock.com, Inc. (OSTK) & Waitr Holdings Inc. (WTRH) - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement GlobeNewswire
01:15PM  IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
12:40PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PUMP, MTCH and MYGN ACCESSWIRE
09:45AM  SHAREHOLDER ALERT: PUMP ADTN MYGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
06:40AM  CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Approaching Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MYGN, OSTK, MTCH ACCESSWIRE
06:35AM  CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Looming Deadlines to File Lead Plaintiff Motions Related to the Following Companies: COF, MYGN, MTCH ACCESSWIRE
Nov-14-19 08:45PM  SHAREHOLDER ALERT: FTCH MYGN AZZ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:45PM  CLASS ACTION UPDATE for DBX, TME and MYGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:14PM  INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in MYGN, TME, and OSTK of Filing Deadlines GlobeNewswire
10:34AM  CLASS ACTION UPDATE for FTCH, CVET, MYGN and YJ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
06:40AM  CLASS ACTION UPDATE: Brodsky & Smith, LLC Reminds Investors of Looming Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MYGN, MTCH, COF ACCESSWIRE
Nov-13-19 06:33PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tencent, Myriad Genetics, Overstock.com, and Waitr Holdings and Encourages Investors to Contact the Firm GlobeNewswire
04:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - MYGN ACCESSWIRE
02:51PM  Pawar Law Group Reminds Investors of NOV. 26 Deadline in Securities Class Action Lawsuit Against Myriad Genetics, Inc. MYGN GlobeNewswire
01:15PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
12:15PM  CLASS ACTION UPDATE for COF, MTCH and MYGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:00AM  DEADLINE ALERT for TME, MYGN, CC, and RUHN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:19AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COF, CADE, MYGN and SDC GlobeNewswire
06:15AM  CLASS ACTION DEADLINES: Brodsky & Smith, LLC Reminds Investors of Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MYGN, MTCH, COF ACCESSWIRE
Nov-12-19 08:50PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CVET, MYGN and AZZ ACCESSWIRE
08:07PM  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching GlobeNewswire
12:25PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ADTN, UNIT and MYGN ACCESSWIRE
11:15AM  MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action - Contact Lieff Cabraser ACCESSWIRE
09:44AM  CLASS ACTION UPDATE for SEE, TME, MYGN and ZEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
06:23AM  CLASS ACTION DEADLINES: Brodsky & Smith, LLC Reminds Investors of Deadlines to File Lead Plaintiff Motions Related to the Following Companies: MTCH, MYGN, COF ACCESSWIRE
Nov-11-19 07:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of WTRH, MYGN and CC ACCESSWIRE
06:24PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline MYGN GlobeNewswire
12:40PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VRAY, MYGN and ZEN ACCESSWIRE
09:53AM  SHAREHOLDER ALERT: GNLN MYGN IRBT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
08:52AM  Myriad Genetics Presents New Test Data in Autoimmune Segment Zacks
07:05AM  Myriads Prequel Prenatal Screen Demonstrates High Performance Across All Fetal-Fraction Levels in Women Undergoing Noninvasive Prenatal Screening GlobeNewswire
Nov-10-19 01:15PM  ROSEN, A LEADING GLOBAL LAW FIRM, Reminds Myriad Genetics, Inc. Investors of Important Deadline in Securities Class Action MYGN Business Wire
09:31AM  Independent Chairman John Henderson Just Bought Shares In Myriad Genetics, Inc. (NASDAQ:MYGN) Simply Wall St.
Myriad Genetics, Inc., a molecular diagnostic company, develops and markets predictive, personalized, and prognostic medicine tests worldwide. The company offers myRisk Hereditary Cancer, a DNA sequencing test for hereditary cancers; BRACAnalysis, a DNA sequencing test to assess the risk of developing breast and ovarian cancer; and riskScore, a personalized medicine tool. It also provides BRACAnalysis CDx, a DNA sequencing test for use in identifying ovarian and HER2 negative metastatic breast cancer patients with deleterious or suspected deleterious germline; GeneSight, a DNA genotyping test to aid psychotropic drug selection for depressed patients; and Vectra, a protein quantification test for assessing the disease activity of rheumatoid arthritis. In addition, the company offers Foresight, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; Prequel, a non-invasive prenatal screening test to screen for severe chromosomal disorders in a fetus; and Prolaris, a RNA expression test for assessing the aggressiveness of prostate cancer. Further, it provides EndoPredict, a RNA expression test for assessing the aggressiveness of breast cancer; myPath Melanoma, a RNA expression test for diagnosing melanoma; and myChoice HRD, a companion diagnostic to measure three modes of homologous recombination deficiency comprising loss of heterozygosity, telomeric allelic imbalance, and large-scale state transitions in cancer cells. Additionally, the company offers biomarker discovery, and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries; and operates an internal medicine emergency hospital primarily for internal medicine and hemodialysis. The company has collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENDERSON JOHN TDirectorNov 07Buy23.461,75041,0562,050Nov 07 01:05 PM
HENDERSON JOHN TDirectorNov 07Buy23.465,250123,16764,353Nov 07 01:05 PM
Capone Mark ChristopherPresident & C.E.O.Aug 01Option Exercise26.38137,0003,614,330511,505Aug 02 05:45 PM
King Gary A.Exec. VP International OpsAug 01Option Exercise23.7360,0001,423,900164,871Aug 02 04:44 PM
Tobin BernardPresident Crescendo BioScienceAug 01Sale40.0011,712468,480146,040Aug 02 04:40 PM
Riggsbee Richard BryanChief Financial OfficerAug 01Sale41.5025,0001,037,575120,566Aug 02 04:32 PM
Capone Mark ChristopherPresident & C.E.O.Aug 01Sale44.00137,0006,028,000440,833Aug 02 05:45 PM
King Gary A.Exec. VP International OpsAug 01Sale43.4960,0002,609,329134,871Aug 02 04:44 PM
McDade Ralph LPresident Myriad RBM, Inc.Mar 12Sale31.001,97561,225122,604Mar 12 05:56 PM
open in yahoo | open in reuters | open in google